Join the club for FREE to access the whole archive and other member benefits.
New reprogramming technology could provide an alternate source of material needed for therapies
Key points from article :
New method manufactures pluripotent cells capable of becoming any cell in the body.
Patent describes multiple techniques for reprogramming cells of the body back to the stem cell state.
Induced Pluripotent Stem Cells (iPS) are typically derived from adult skin or blood cells.
iPSCs can be used for drug discovery or as an alternative source of cell types for regenerative therapies.
Click on resource name for more details.
Biotechnology company focused on the development of novel therapeutics for age-related degenerative disease
Mr. Culley occupies the position of President, CEO & Independent Director at Lineage Cell Therapeutics, Inc.
Lineage is a clinical-stage biotechnology company developing novel cell therapies
